K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Jens Otto Lunde Jørgensen
also known as J JORGENSEN, J Jorgensen, J JØRGENSEN
Aarhus University · Aarhus University Hospital · University of Copenhagen · Cedars-Sinai Medical Center
About this author
Works
670
Cited by
29,232
h-index
87
i10
383
ORCID ↗
Top papers
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Tavs Folmer Andersen, Morten Madsen, Jens Otto Lunde Jørgensen, et al.
·
1999
·
PubMed
↗ 2,037
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Møller, Jens Otto Lunde Jørgensen
·
2009
·
Endocrine Reviews
↗ 1,020
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jens Otto Lunde Jørgensen, Leif Thuesen, Thorsten Ingemann-Hansen, et al.
·
1989
·
The Lancet
↗ 895
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study<sup>1</sup>
Jörgen Lindholm, Svend Juul, Jens Otto Lunde Jørgensen, et al.
·
2001
·
The Journal of Clinical Endocrinology & Metabolism
↗ 614
OA
Weight loss increases circulating levels of ghrelin in human obesity
Troels Krarup Hansen, Rolf Dall, Hiroshi Hosoda, et al.
·
2002
·
Clinical Endocrinology
↗ 496
Use of Glucocorticoids and Risk of Venous Thromboembolism
Sigrun Alba Johannesdottir, Erzsébet Horváth–Puhó, Olaf M. Dekkers, et al.
·
2013
·
JAMA Internal Medicine
↗ 454
High-Dose Resveratrol Supplementation in Obese Men
Morten Møller Poulsen, P. Vestergaard, Berthil F. Clasen, et al.
·
2012
·
Diabetes
↗ 441
OA
Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Leonie H. A. Broersen, Alberto M. Pereira, Jens Otto Lunde Jørgensen, et al.
·
2015
·
The Journal of Clinical Endocrinology & Metabolism
↗ 439
OA
Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
Olaf M. Dekkers, Erzsébet Horváth–Puhó, Jens Otto Lunde Jørgensen, et al.
·
2013
·
The Journal of Clinical Endocrinology & Metabolism
↗ 419
OA
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Thomas S. Nielsen, Niels Jessen, Jens Otto Lunde Jørgensen, et al.
·
2014
·
Journal of Molecular Endocrinology
↗ 366
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack, Olaf M Dekkers, Stephan Petersenn, et al.
·
2018
·
European Journal of Endocrinology
↗ 274
OA
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Olaf M. Dekkers, Joep Lagró, Pia Burman, et al.
·
2009
·
The Journal of Clinical Endocrinology & Metabolism
↗ 227
OA